Understanding Meth Addiction Treatment
Methamphetamine use has surged across the United States, with overdose deaths involving stimulants increasing 34-fold from 2011 to 2023. Unlike opioid use disorder, there are currently no FDA-approved medications for meth addiction, making behavioral therapy the cornerstone of treatment.
The Matrix Model — a 16-week intensive outpatient protocol combining CBT, family education, 12-step support, drug testing, and contingency management — has the strongest evidence base for stimulant use disorders. Inpatient programs are recommended for severe cases or when outpatient attempts have failed.
Why Meth Requires Longer Treatment
Chronic methamphetamine use causes significant neurotoxicity — particularly to dopamine systems governing motivation, pleasure, and cognitive function. Neuroimaging studies show these changes take 12-18 months to substantially reverse. This biological reality means 28-day programs are often insufficient; 60-90 day residential stays with extended outpatient aftercare produce the best outcomes.
Sources & References
- [1] NIDA. Methamphetamine DrugFacts. 2024.
- [2] SAMHSA. Treatment for Stimulant Use Disorders. TIP 33. 2021.
- [3] CDC. Psychostimulant Overdose Deaths. 2024.